Comparison Overview

ENT and Allergy Associates

VS

Hamad Medical Corporation

ENT and Allergy Associates

660 White Plains Road, Suite 400, Tarrytown, NY, US, 10591
Last Update: 2025-12-01
Between 750 and 799

The nation's largest Ear, Nose, Throat, Allergy & Audiology practice with 450+ clinicians across NY, NJ, and PA.

NAICS: 621
NAICS Definition: Ambulatory Health Care Services
Employees: 1,247
Subsidiaries: 0
12-month incidents
0
Known data breaches
1
Attack type number
1

Hamad Medical Corporation

PO Box 3488, Doha, QA
Last Update: 2025-12-01
Between 750 and 799

Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East. For more than three decades, HMC has been dedicated to delivering the safest, most effective and compassionate care to all its patients. HMC manages twelve hospitals – nine specialist hospitals and three community hospitals – as well as the National Ambulance Service and home and residential care services. In January 2016, HMC achieved the significant distinction of becoming the first healthcare system across the globe to have all its hospitals accredited by Joint Commission International under the Academic Medical Center accreditation program. Additionally, the National Ambulance Service, Home Healthcare Service, Stroke Service and Palliative Care, have all received this prestigious accreditation since 2011. To meet the needs of a rapidly growing population, HMC has announced ambitious plans to expand capacity across its network through to 2030. HMC is leading the development of the region’s first academic health system – combining innovative research, top-class education and excellent clinical care – and is committed to building a legacy of healthcare expertise in Qatar. HMC collaborates with key partners who are experts in Qatar and beyond, including Weill Cornell Medical College-Qatar, the Institute for Healthcare Improvement and Partners Healthcare, Boston. HMC is also the first hospital system in the Middle East to achieve institutional accreditation from the Accreditation Council of Graduate Medical Education – International (ACGME-I), which demonstrates excellence in the way medical graduates are trained through residency, internship and fellowship programs. For more information about working at HMC, please visit www.hmc.org.qa/en/employees_careers/employees_careers.aspx

NAICS: 621
NAICS Definition: Ambulatory Health Care Services
Employees: 19,214
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/ent-and-allergy-associates.jpeg
ENT and Allergy Associates
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/hamad-medical-corporation.jpeg
Hamad Medical Corporation
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
ENT and Allergy Associates
100%
Compliance Rate
0/4 Standards Verified
Hamad Medical Corporation
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Practices Industry Average (This Year)

No incidents recorded for ENT and Allergy Associates in 2025.

Incidents vs Medical Practices Industry Average (This Year)

No incidents recorded for Hamad Medical Corporation in 2025.

Incident History — ENT and Allergy Associates (X = Date, Y = Severity)

ENT and Allergy Associates cyber incidents detection timeline including parent company and subsidiaries

Incident History — Hamad Medical Corporation (X = Date, Y = Severity)

Hamad Medical Corporation cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/ent-and-allergy-associates.jpeg
ENT and Allergy Associates
Incidents

Date Detected: 6/2016
Type:Breach
Blog: Blog
https://images.rankiteo.com/companyimages/hamad-medical-corporation.jpeg
Hamad Medical Corporation
Incidents

No Incident

FAQ

Hamad Medical Corporation company demonstrates a stronger AI Cybersecurity Score compared to ENT and Allergy Associates company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

ENT and Allergy Associates company has historically faced a number of disclosed cyber incidents, whereas Hamad Medical Corporation company has not reported any.

In the current year, Hamad Medical Corporation company and ENT and Allergy Associates company have not reported any cyber incidents.

Neither Hamad Medical Corporation company nor ENT and Allergy Associates company has reported experiencing a ransomware attack publicly.

ENT and Allergy Associates company has disclosed at least one data breach, while the other Hamad Medical Corporation company has not reported such incidents publicly.

Neither Hamad Medical Corporation company nor ENT and Allergy Associates company has reported experiencing targeted cyberattacks publicly.

Neither ENT and Allergy Associates company nor Hamad Medical Corporation company has reported experiencing or disclosing vulnerabilities publicly.

Neither ENT and Allergy Associates nor Hamad Medical Corporation holds any compliance certifications.

Neither company holds any compliance certifications.

Neither ENT and Allergy Associates company nor Hamad Medical Corporation company has publicly disclosed detailed information about the number of their subsidiaries.

Hamad Medical Corporation company employs more people globally than ENT and Allergy Associates company, reflecting its scale as a Medical Practices.

Neither ENT and Allergy Associates nor Hamad Medical Corporation holds SOC 2 Type 1 certification.

Neither ENT and Allergy Associates nor Hamad Medical Corporation holds SOC 2 Type 2 certification.

Neither ENT and Allergy Associates nor Hamad Medical Corporation holds ISO 27001 certification.

Neither ENT and Allergy Associates nor Hamad Medical Corporation holds PCI DSS certification.

Neither ENT and Allergy Associates nor Hamad Medical Corporation holds HIPAA certification.

Neither ENT and Allergy Associates nor Hamad Medical Corporation holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

vLLM is an inference and serving engine for large language models (LLMs). Prior to 0.11.1, vllm has a critical remote code execution vector in a config class named Nemotron_Nano_VL_Config. When vllm loads a model config that contains an auto_map entry, the config class resolves that mapping with get_class_from_dynamic_module(...) and immediately instantiates the returned class. This fetches and executes Python from the remote repository referenced in the auto_map string. Crucially, this happens even when the caller explicitly sets trust_remote_code=False in vllm.transformers_utils.config.get_config. In practice, an attacker can publish a benign-looking frontend repo whose config.json points via auto_map to a separate malicious backend repo; loading the frontend will silently run the backend’s code on the victim host. This vulnerability is fixed in 0.11.1.

Risk Information
cvss3
Base: 7.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:H/A:H
Description

fastify-reply-from is a Fastify plugin to forward the current HTTP request to another server. Prior to 12.5.0, by crafting a malicious URL, an attacker could access routes that are not allowed, even though the reply.from is defined for specific routes in @fastify/reply-from. This vulnerability is fixed in 12.5.0.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Prior to 21.0.2, 20.3.15, and 19.2.17, A Stored Cross-Site Scripting (XSS) vulnerability has been identified in the Angular Template Compiler. It occurs because the compiler's internal security schema is incomplete, allowing attackers to bypass Angular's built-in security sanitization. Specifically, the schema fails to classify certain URL-holding attributes (e.g., those that could contain javascript: URLs) as requiring strict URL security, enabling the injection of malicious scripts. This vulnerability is fixed in 21.0.2, 20.3.15, and 19.2.17.

Risk Information
cvss4
Base: 8.5
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Gin-vue-admin is a backstage management system based on vue and gin. In 2.8.6 and earlier, attackers can delete any file on the server at will, causing damage or unavailability of server resources. Attackers can control the 'FileMd5' parameter to delete any file and folder.

Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Portkey.ai Gateway is a blazing fast AI Gateway with integrated guardrails. Prior to 1.14.0, the gateway determined the destination baseURL by prioritizing the value in the x-portkey-custom-host request header. The proxy route then appends the client-specified path to perform an external fetch. This can be maliciously used by users for SSRF attacks. This vulnerability is fixed in 1.14.0.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X